Titre : Mucines

Mucines : Questions médicales fréquentes

Termes MeSH sélectionnés :

Cholangiocarcinoma
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Mucines : Questions médicales les plus fréquentes", "headline": "Mucines : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Mucines : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-06-13", "dateModified": "2025-03-10", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Mucines" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Mucoprotéines", "url": "https://questionsmedicales.fr/mesh/D009088", "about": { "@type": "MedicalCondition", "name": "Mucoprotéines", "code": { "@type": "MedicalCode", "code": "D009088", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.395.560" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mucines gastriques", "alternateName": "Gastric Mucins", "url": "https://questionsmedicales.fr/mesh/D005752", "about": { "@type": "MedicalCondition", "name": "Mucines gastriques", "code": { "@type": "MedicalCode", "code": "D005752", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.395.560.631.100" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Mucine-5AC", "alternateName": "Mucin 5AC", "url": "https://questionsmedicales.fr/mesh/D055271", "about": { "@type": "MedicalCondition", "name": "Mucine-5AC", "code": { "@type": "MedicalCode", "code": "D055271", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.395.560.631.100.500" } } }, { "@type": "MedicalWebPage", "name": "Mucine-6", "alternateName": "Mucin-6", "url": "https://questionsmedicales.fr/mesh/D055272", "about": { "@type": "MedicalCondition", "name": "Mucine-6", "code": { "@type": "MedicalCode", "code": "D055272", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.395.560.631.100.750" } } } ] }, { "@type": "MedicalWebPage", "name": "Mucine-2", "alternateName": "Mucin-2", "url": "https://questionsmedicales.fr/mesh/D055262", "about": { "@type": "MedicalCondition", "name": "Mucine-2", "code": { "@type": "MedicalCode", "code": "D055262", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.395.560.631.161" } } }, { "@type": "MedicalWebPage", "name": "Sialomucines", "alternateName": "Sialomucins", "url": "https://questionsmedicales.fr/mesh/D052116", "about": { "@type": "MedicalCondition", "name": "Sialomucines", "code": { "@type": "MedicalCode", "code": "D052116", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "D12.776.395.560.631.650" } } } ], "about": { "@type": "MedicalCondition", "name": "Mucines", "alternateName": "Mucins", "code": { "@type": "MedicalCode", "code": "D009077", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Sara K Lindén", "url": "https://questionsmedicales.fr/author/Sara%20K%20Lind%C3%A9n", "affiliation": { "@type": "Organization", "name": "Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine." } }, { "@type": "Person", "name": "Henrik Sundh", "url": "https://questionsmedicales.fr/author/Henrik%20Sundh", "affiliation": { "@type": "Organization", "name": "Department of Biological and Environmental Sciences, University of Gothenburg, 405 30, Gothenburg, Sweden." } }, { "@type": "Person", "name": "John Benktander", "url": "https://questionsmedicales.fr/author/John%20Benktander", "affiliation": { "@type": "Organization", "name": "Department of Medical Biochemistry and Cell Biology, Institute of Biomedicine." } }, { "@type": "Person", "name": "Kristina Sundell", "url": "https://questionsmedicales.fr/author/Kristina%20Sundell", "affiliation": { "@type": "Organization", "name": "Department of Biological and Environmental Sciences, University of Gothenburg, 405 30, Gothenburg, Sweden." } }, { "@type": "Person", "name": "Jessica R Kramer", "url": "https://questionsmedicales.fr/author/Jessica%20R%20Kramer", "affiliation": { "@type": "Organization", "name": "Department of Biomedical Engineering, University of Utah, Salt Lake City, Utah 84112, United States." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "Case report: Immunotherapy plus chemotherapy and stereotactic ablative radiotherapy (ICSABR): a novel treatment combination for Epstein-Barr virus-associated lymphoepithelioma-like intrahepatic cholangiocarcinoma.", "datePublished": "2023-08-08", "url": "https://questionsmedicales.fr/article/37614316", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fphar.2023.1147449" } }, { "@type": "ScholarlyArticle", "name": "A novel nutritional score based on serum triglyceride and protein levels predicts outcomes of intrahepatic cholangiocarcinoma after curative hepatectomy: A multi-center study of 631 patients.", "datePublished": "2022-09-21", "url": "https://questionsmedicales.fr/article/36211491", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fnut.2022.964591" } }, { "@type": "ScholarlyArticle", "name": "Tumor budding in pre-neoadjuvant biopsy and post-neoadjuvant resection specimens is associated with poor prognosis in intrahepatic cholangiocarcinoma-a cohort study of 147 cases by modified ITBCC criteria.", "datePublished": "2024-10-10", "url": "https://questionsmedicales.fr/article/39384623", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00428-024-03937-y" } }, { "@type": "ScholarlyArticle", "name": "csi-miR-96-5p delivered by Clonorchis sinensis extracellular vesicles promotes intrahepatic cholangiocarcinoma proliferation and migration via the ferroptosis-related PTEN/SLC7A11/GPX4 axis.", "datePublished": "2023-12-20", "url": "https://questionsmedicales.fr/article/38124152", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1186/s13071-023-06075-7" } }, { "@type": "ScholarlyArticle", "name": "Preoperative peripheral blood inflammatory markers especially the fibrinogen-to-lymphocyte ratio and novel FLR-N score predict the prognosis of patients with early-stage resectable extrahepatic cholangiocarcinoma.", "datePublished": "2022-10-31", "url": "https://questionsmedicales.fr/article/36387142", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.3389/fonc.2022.1003845" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Acides aminés, peptides et protéines", "item": "https://questionsmedicales.fr/mesh/D000602" }, { "@type": "ListItem", "position": 3, "name": "Protéines", "item": "https://questionsmedicales.fr/mesh/D011506" }, { "@type": "ListItem", "position": 4, "name": "Glycoprotéines", "item": "https://questionsmedicales.fr/mesh/D006023" }, { "@type": "ListItem", "position": 5, "name": "Mucoprotéines", "item": "https://questionsmedicales.fr/mesh/D009088" }, { "@type": "ListItem", "position": 6, "name": "Mucines", "item": "https://questionsmedicales.fr/mesh/D009077" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Mucines - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Mucines", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-09", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Mucines", "description": "Comment diagnostiquer une anomalie des mucines ?\nQuels examens sont utilisés pour évaluer les mucines ?\nLes tests génétiques sont-ils utiles pour les mucines ?\nQuels symptômes peuvent indiquer un problème de mucines ?\nPeut-on mesurer les niveaux de mucines dans le sang ?", "url": "https://questionsmedicales.fr/mesh/D009077?mesh_terms=Cholangiocarcinoma&page=205#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Mucines", "description": "Quels sont les symptômes d'une carence en mucines ?\nLes mucines affectent-elles la digestion ?\nComment les mucines influencent-elles la respiration ?\nLes mucines peuvent-elles causer des allergies ?\nQuels signes indiquent une inflammation liée aux mucines ?", "url": "https://questionsmedicales.fr/mesh/D009077?mesh_terms=Cholangiocarcinoma&page=205#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Mucines", "description": "Comment prévenir les troubles liés aux mucines ?\nLes soins oculaires réguliers aident-ils les mucines ?\nL'hygiène buccale influence-t-elle les mucines ?\nLes allergies peuvent-elles être prévenues pour protéger les mucines ?\nLe tabagisme affecte-t-il la santé des mucines ?", "url": "https://questionsmedicales.fr/mesh/D009077?mesh_terms=Cholangiocarcinoma&page=205#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Mucines", "description": "Quels traitements existent pour les troubles des mucines ?\nLes mucines peuvent-elles être remplacées par des médicaments ?\nY a-t-il des thérapies naturelles pour les mucines ?\nLes interventions chirurgicales sont-elles nécessaires pour les mucines ?\nComment les changements alimentaires affectent-ils les mucines ?", "url": "https://questionsmedicales.fr/mesh/D009077?mesh_terms=Cholangiocarcinoma&page=205#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Mucines", "description": "Quelles complications peuvent survenir avec des mucines anormales ?\nLes mucines anormales peuvent-elles causer des cancers ?\nComment les mucines affectent-elles la qualité de vie ?\nLes complications respiratoires sont-elles liées aux mucines ?\nLes troubles des mucines peuvent-ils affecter la fertilité ?", "url": "https://questionsmedicales.fr/mesh/D009077?mesh_terms=Cholangiocarcinoma&page=205#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Mucines", "description": "Quels facteurs augmentent le risque de troubles des mucines ?\nLe stress influence-t-il la santé des mucines ?\nLes infections fréquentes sont-elles un facteur de risque ?\nL'alimentation joue-t-elle un rôle dans la santé des mucines ?\nLes antécédents familiaux influencent-ils les troubles des mucines ?", "url": "https://questionsmedicales.fr/mesh/D009077?mesh_terms=Cholangiocarcinoma&page=205#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une anomalie des mucines ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de laboratoire et des biopsies peuvent être utilisés pour évaluer les mucines." } }, { "@type": "Question", "name": "Quels examens sont utilisés pour évaluer les mucines ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "L'immunohistochimie et l'électrophorèse des protéines sont couramment utilisés." } }, { "@type": "Question", "name": "Les tests génétiques sont-ils utiles pour les mucines ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Oui, ils peuvent aider à identifier des mutations liées à des troubles des mucines." } }, { "@type": "Question", "name": "Quels symptômes peuvent indiquer un problème de mucines ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme la sécheresse des muqueuses ou des infections fréquentes peuvent survenir." } }, { "@type": "Question", "name": "Peut-on mesurer les niveaux de mucines dans le sang ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des tests sanguins peuvent évaluer les niveaux de mucines dans certaines conditions." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une carence en mucines ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent sécheresse des yeux, de la bouche et des voies respiratoires." } }, { "@type": "Question", "name": "Les mucines affectent-elles la digestion ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une production insuffisante de mucines peut entraîner des troubles digestifs." } }, { "@type": "Question", "name": "Comment les mucines influencent-elles la respiration ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Elles protègent les voies respiratoires et aident à piéger les particules étrangères." } }, { "@type": "Question", "name": "Les mucines peuvent-elles causer des allergies ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Une surproduction de mucines peut contribuer à des réactions allergiques dans certaines conditions." } }, { "@type": "Question", "name": "Quels signes indiquent une inflammation liée aux mucines ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Rougeur, gonflement et douleur dans les zones affectées peuvent être des signes." } }, { "@type": "Question", "name": "Comment prévenir les troubles liés aux mucines ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Maintenir une bonne hydratation et éviter les irritants environnementaux sont essentiels." } }, { "@type": "Question", "name": "Les soins oculaires réguliers aident-ils les mucines ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des examens oculaires réguliers peuvent prévenir les problèmes liés aux mucines oculaires." } }, { "@type": "Question", "name": "L'hygiène buccale influence-t-elle les mucines ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une bonne hygiène buccale peut prévenir les infections et maintenir la santé des mucines." } }, { "@type": "Question", "name": "Les allergies peuvent-elles être prévenues pour protéger les mucines ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les allergènes connus peut réduire le risque d'inflammation des mucines." } }, { "@type": "Question", "name": "Le tabagisme affecte-t-il la santé des mucines ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le tabagisme peut endommager les mucines et aggraver les problèmes respiratoires." } }, { "@type": "Question", "name": "Quels traitements existent pour les troubles des mucines ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent des substituts de larmes et des médicaments anti-inflammatoires." } }, { "@type": "Question", "name": "Les mucines peuvent-elles être remplacées par des médicaments ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des médicaments peuvent aider à augmenter la production de mucines dans certaines conditions." } }, { "@type": "Question", "name": "Y a-t-il des thérapies naturelles pour les mucines ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Certaines thérapies comme l'hydratation et les huiles essentielles peuvent aider." } }, { "@type": "Question", "name": "Les interventions chirurgicales sont-elles nécessaires pour les mucines ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Dans certains cas, des interventions chirurgicales peuvent être nécessaires pour corriger des anomalies." } }, { "@type": "Question", "name": "Comment les changements alimentaires affectent-ils les mucines ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en oméga-3 et en antioxydants peut améliorer la santé des mucines." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec des mucines anormales ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Des infections chroniques et des inflammations peuvent être des complications fréquentes." } }, { "@type": "Question", "name": "Les mucines anormales peuvent-elles causer des cancers ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Certaines anomalies des mucines sont associées à un risque accru de cancers spécifiques." } }, { "@type": "Question", "name": "Comment les mucines affectent-elles la qualité de vie ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Des troubles des mucines peuvent entraîner une gêne et des limitations fonctionnelles." } }, { "@type": "Question", "name": "Les complications respiratoires sont-elles liées aux mucines ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, une production insuffisante de mucines peut entraîner des complications respiratoires." } }, { "@type": "Question", "name": "Les troubles des mucines peuvent-ils affecter la fertilité ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Certaines conditions liées aux mucines peuvent avoir un impact sur la fertilité masculine et féminine." } }, { "@type": "Question", "name": "Quels facteurs augmentent le risque de troubles des mucines ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "L'âge, les maladies auto-immunes et l'exposition à des irritants sont des facteurs de risque." } }, { "@type": "Question", "name": "Le stress influence-t-il la santé des mucines ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le stress chronique peut affecter la production et la fonction des mucines." } }, { "@type": "Question", "name": "Les infections fréquentes sont-elles un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des infections répétées peuvent altérer la production normale de mucines." } }, { "@type": "Question", "name": "L'alimentation joue-t-elle un rôle dans la santé des mucines ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation déséquilibrée peut augmenter le risque de troubles des mucines." } }, { "@type": "Question", "name": "Les antécédents familiaux influencent-ils les troubles des mucines ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de maladies liées aux mucines peuvent augmenter le risque." } } ] } ] }

Sources (2064 au total)

A novel nutritional score based on serum triglyceride and protein levels predicts outcomes of intrahepatic cholangiocarcinoma after curative hepatectomy: A multi-center study of 631 patients.

High serum triglyceride (STG) level is a well-established pathogenic factor for cardiovascular diseases and is associated with the risk of various malignancies. Nevertheless, the role of STG level in ... A total of 631 ICC patients treated with curative hepatectomy in two centers (517 in the discovery set and 114 in the validation set) were retrospectively analyzed. Kaplan-Meier survival analysis was ... Patients with increased STG levels and decreased albumin-globulin score (AGS) were correlated with improved overall survival (OS) and recurrence-free survival (RFS). STG level ≥ 1 mmol/L was an indepe... The current study presented strong evidence that ICC patients with higher preoperative STG levels had preferred long-term surgical outcomes. The novel nutritional score based on serum triglyceride, al...

csi-miR-96-5p delivered by Clonorchis sinensis extracellular vesicles promotes intrahepatic cholangiocarcinoma proliferation and migration via the ferroptosis-related PTEN/SLC7A11/GPX4 axis.

Clonorchis sinensis (CS) is classified as a group 1 carcinogen and can cause intrahepatic cholangiocarcinoma (ICC). CS extracellular vesicles (CsEVs) play important roles in mediating communication be... Tissue samples were collected from ICC patients with CS infection (CS-ICC) or without CS infection (NC-ICC). The levels of csi-miR-96-5p and PTEN gene were determined by quantitative polymerase chain ... High csi-miR-96-5p and low PTEN expression was observed in CS-ICC tissues and was associated with poor overall survival. csi-miR-96-5p was highly enriched in CsEVs and was taken up by ICC cells. csi-m... csi-miR-96-5p delivered by CsEVs reduced ferroptosis by regulating the expression of the PTEN/SLC7A11/GPX4 axis, thereby promoting ICC proliferation and migration. For the first time to our knowledge,...

Preoperative peripheral blood inflammatory markers especially the fibrinogen-to-lymphocyte ratio and novel FLR-N score predict the prognosis of patients with early-stage resectable extrahepatic cholangiocarcinoma.

Systemic inflammation is important in the development of extrahepatic cholangiocarcinoma (ECC). The aim of this study was to compare the prognostic power of preoperative peripheral blood inflammatory ... A total of 140 patients with resectable ECC and 140 healthy controls (HCs) were recruited for the study. The Mann-Whitney U test was used to evaluate the differences in inflammatory markers between gr... Patients with resectable ECC had significantly higher levels of neutrophils, monocytes, fibrinogen, FLR, FAR, FPR, NLR, PLR, and MLR and lower levels of lymphocytes, albumin, and prealbumin than HCs (... The prognostic roles of inflammatory markers in patients with resectable ECC were different. The preoperative neutrophil count, FLR and FLR-N score could serve as noninvasive markers for predicting th...

Clinical Utility of Personalized Serum IgG Subclass Ratios for the Differentiation of IgG4-Related Sclerosing Cholangitis (IgG4-SC) from Primary Sclerosing Cholangitis (PSC) and Cholangiocarcinoma (CCA).

The differential diagnosis of immunoglobulin G4-sclerosing cholangitis (IgG4-SC) from primary sclerosing cholangitis (PSC) or cholangiocarcinoma (CCA) is important. In this study, we aimed to find the... In total, 31 patients with IgG4-SC, 27 patients with PSC, and 40 patients with CCA were enrolled from 2003 to 2017 at a single tertiary referral center. We retrospectively assessed the IgG4, IgG4/IgG1... In differentiating IgG4-SC from PSC, the accuracies of IgG4/IgG1 ≥ 0.087 and of IgG4/(IgG1+IgG3) ≥ 0.081 were significantly higher than that of IgG4 ≥ 135 mg/dL alone (78% vs. 66%,... The serum IgG4/IgG1 or IgG4/(IgG1+IgG3) level may help to differentiate IgG4-SC from PSC. IgG4 alone is the most accurate serologic marker for the differentiation of IgG4-SC from CCA....

Robotic Right Hepatectomy with En Bloc Caudatectomy for Bismuth IIIa Hilar Cholangiocarcinoma: A Video Demonstration of Left-Liver-First Anterior Radical Modular Orthotopic Right Hemihepatectomy.

Minimally invasive resection for perihilar cholangiocarcinoma is a complicated and technically demanding surgical procedure. Radical surgical resection is regarded as the best treatment for hepatic hi... A 45-year-old female patient was diagnosed with a hilar cholangiocarcinoma. Following a 7-day percutaneous biliary drainage of the left intrahepatic bile duct and obtaining informed consent, we perfor... Robotic right hepatectomy with caudate lobectomy was successfully performed in 450 min, with an estimated blood loss of 200 ml. The histological grading was determined as T1aN1M0 (stage IIIB) on the b... Robotic left-liver-first anterior radical modular orthotopic right hemihepatectomy for Bismuth IIIa HCCA is both safe and feasible. This method may provide a new surgical approach for patients with ty...

Hepatic artery infusion pump (HAIP) therapy in combination with targeted delivery of IL-12 for patients with metastatic colorectal cancer or intrahepatic cholangiocarcinoma: a phase II trial protocol.

Treatment of advanced liver tumors remains challenging. Although immune checkpoint inhibition has revolutionized treatment for many cancers, responses in colorectal liver metastases and biliary tract ... Patients with unresectable metastatic colorectal cancer (mCRC) or unresectable intrahepatic cholangiocarcinoma (ICC) will receive synchronization of subcutaneous PDS01ADC with floxuridine delivered vi... Poor clinical response of these liver tumors to immunotherapy is likely due to various factors, including poor immune infiltrate into the tumor and immunosuppression by the tumor microenvironment. By ... ClinicalTrials.gov (ID NCT05286814 version 2023-10-18); https://clinicaltrials.gov/study/NCT05286814?term=NCT05286814&rank=1....

The Clinical Association Between the Inflammation-Nutritional Condition and Prognosis of Locally Advanced Intrahepatic Cholangiocarcinoma After R0 Resection: Evidence from Competing Risk and Propensity Matching Analysis.

Intrahepatic cholangiocarcinoma (ICC) correlates with poor outcomes, necessitating the identification of prognostic factors from an inflammation-nutritional perspective in locally advanced ICC patient... We retrospectively reviewed the medical records of 159 locally advanced ICC patients from Sun Yat-sen University Cancer Center. Univariate and multivariate Cox regression analysis, as well as competin... Considering non-cancer-specific death as competing risk factors, both systemic immune-inflammation index (SII, HR: 1.934) and prognostic nutrition index (PNI, HR: 0.604) emerged as significant prognos... Individual inflammatory and nutritional status significantly impact the prognosis of locally advanced ICC undergoing R0 hapectomy. Oncologists should consider incorporating inflammation-nutritional co...

Simultaneous robot-assisted colorectal surgery for sigmoid colon cancer and portal vein embolization from the inferior mesenteric vein for intrahepatic cholangiocarcinoma: A case report and literature review.

The treatment of multiple cancers requires multidisciplinary expertise. In this case, we experienced a multiple cancers case, sigmoid colon cancer and intrahepatic cholangiocarcinoma that required pre... This patient had intrahepatic cholangiocarcinoma and sigmoid colon cancer. A radical cure for intrahepatic cholangiocarcinoma was expected by left liver lobectomy. Because of concerns about postoperat... PVE is a very important technique for massive hepatic resection. Percutaneous trans-hepatic approach has the potential to damage vessels, bile duct, normal liver. Venous approaches, including via ICV,... PVE via IMV was successfully performed without complications. In multiple cancers case, this approach would be better approach than any other PVE approach like this case....